I don't know if you were talking about me, however for what it's worth I been invested in this company for over a year. I've been following the board I just haven't said anything until now.
And I agree with what you and others on this board have been saying, I don't like Anthony Cataldo as their CEO. His lack of transparency in regards to Oxis has made it difficult for investors to understand how the company is doing and thus has negatively affected the stock price.
Just click on figures and data on the link below. I think you'll agree with me (and the data) in that the TriKE platform looks promising. I believe the clinical trial with Altor Bioscience will go well.
News 
Market Data 
Discover 
